Lifecore Biomedical, Inc. De (LFCR) Non-Current Debt (2011 - 2025)

Lifecore Biomedical's Non-Current Debt history runs 15 years deep, the most recent figure standing at $5.8 million for Q2 2025.

• In Q2 2025, Non-Current Debt fell 94.25% year-over-year to $5.8 million; the TTM figure through May 2025 stood at $5.8 million (down 94.25% YoY), while the FY2025 annual figure was $5.8 million, down 94.25% from the prior year.
• Non-Current Debt was $5.8 million for Q2 2025 at Lifecore Biomedical, down from $8.3 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $164.9 million in Q2 2021 to a low of $5.8 million in Q2 2025.
• Historically, Non-Current Debt has averaged $67.7 million across 5 years, with a median of $79.6 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Non-Current Debt jumped 502.1% in 2024, then sank 94.25% in 2025.
• A 5-year view of Non-Current Debt shows it stood at $124.2 million in 2021, then tumbled by 35.91% to $79.6 million in 2022, then sank by 78.8% to $16.9 million in 2023, then tumbled by 49.64% to $8.5 million in 2024, then tumbled by 31.75% to $5.8 million in 2025.
• The last three Non-Current Debt figures came in at $5.8 million (Q2 2025), $8.3 million (Q1 2025), and $8.5 million (Q4 2024), per Business Quant data.